Oncologia_Laboratori

 

Universita' Politecnica delle Marche

Dipartimento di Scienze Cliniche e Molecolari

 

LABORATORIO DI ONCOLOGIA

       

Staff:

Prof.ssa Rossana Berardi (Direttore) (Prof.ssa Ordinaria)

Prof. Riccardo Giampieri (prof. Associato)

Dott. Alessandro Parisi (Ricercatore)

Dott.ssa Francesca Bianchi (Tecnico D convenzionato)

Dott.ssa Laura Belvederesi (Tecnico D partime)

Dott.ssa Cristiana Brugiati (Tecnico C)

Ersilia Tarabelli (Tecnico C)

Dott.ssa Elisa Ambrosini (Dottoranda che termina il 31 ottobre e assegnista dal 1’ novembre)

Dott.ssa Natalia Chiodi (Dottoranda)

Dott.ssa Valentina Tarantino (Dottoranda)

Strumentazione

1 NGS S5 + ION CHEF

1 SEQUENZIATORE MULTICAPILLARE DX (CE-IVD)

1 SEQUENZIATORE MULTICAPILLARE RUO

6 TERMOCICLATORI

2 REALTIME

1 CENTRIFUGA DA BANCO

3 MICROCENTRIFUGHE DA BANCO DI CUI 1 REFRIGERATA

2 ESTRATTORI AUTOMATICI

2 QUBIT

1 NANODROP

1 ELIX 5

1 PRODUTTORE DI GHIACCIO

2 CONGELATORI -80°C

3 CONGELATORI -30°C

3 FRIGORIFERI +4°C

1 CAPPA CHIMICA

1 CAPPA A FLUSSO ALMINARE

2 CAMERETTE ELETTROFORETICHE

2 VORTEX

 

Pubblicazioni

 

  1. In extenso

 

  1. Rossana Berardi, Alessandro Parisi, Marco Maruzzo, Marco Bellani, Giordano Domenico Beretta, Mauro Boldrini, Luigi Cavanna, Stefania Gori, Elisabetta Iannelli, Anna Maria Mancuso, Massimiliano Marinelli, Vera Martinella, Michele Musso, Roberto Papa, Antonio Russo, Valentina Tarantino, Mirella Taranto, Saverio Cinieri. Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM). Support Care Cancer. 2024 Aug 26;32(9):613. doi: 10.1007/s00520-024-08786-8.

 

  1. D Ciardiello, L B Bielo, S Napolitano, E Martinelli, T Troiani, A Nicastro, T P Latiano, P Parente, E Maiello, A Avallone, N Normanno, S Pisconti, C Nisi, R Bordonaro, A E Russo, E Tamburrini, I Toma, C Lotesoriere, S Vallarelli, M G Zampino, N Fazio, G Curigliano, F De Vita, F Ciardiello, G Martini; CAPRI-2 GOIM study Group. Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial. Ann Oncol. 2024 Aug 28:S0923-7534(24)03914-0. doi: 10.1016/j.annonc.2024.08.2334.

 

  1. Fabiana Perrone, Federica Pecci, Michele Maffezzoli, Giulia Claire Giudice, Valeria Cognigni, Giulia Mazzaschi, Luca Cantini, Luca Santamaria, Francesco Paoloni, Marco Luigi Bruno Rocchi, Matilde Coriano', Alessandro Acunzo, Federico Quaini, Marcello Tiseo, Saini S Kamal, Rossana Berardi, Sebastiano Buti. Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy. Immunotherapy. 2024 Aug 6:1-10. doi: 10.1080/1750743X.2024.2377953.

 

  1. Franca Benini, Rossana Berardi, Laura Bogliolo, Fabio Borrometi, Francesco Cellini, Leonardo Consoletti, Gabriele Finco, Diego Fornasari, Marta Gentili, Gino Gobber, Pierangelo Lora Aprile, Ernesto Maranzano, Franco Marinangeli, Paola Miglioranzi, Alessia Violini. The Need For Consistent Epidemiological Data On Chronic Pain In Italy And Beyond. Minerva Anestesiol. 2024 Jul 25. doi: 10.23736/S0375-9393.24.18288-0.

 

  1. Chiara Liverani, Alberto Bongiovanni, Flavia Foca, Francesca Bergamo, Silvana Leo, Sara Pusceddu, Fabio Gelsomino, Maria Pia Brizzi, Giovanni Di Meglio, Francesca Spada, Stefano Tamberi, Ivan Lolli, Mauro Cives, Riccardo Marconcini, Francesca Pucci, Rossana Berardi, Lorenzo Antonuzzo, Giuseppe Badalamenti, Daniele Santini, Federica Recine, Silvia Vanni, Michela Tebaldi, Stefano Severi, Britt Rudnas, Oriana Nanni, Nicoletta Ranallo, Laura Crudi, Luana Calabrò, Toni Ibrahim. A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas. Eur J Cancer. 2024 May 25:208:114129. doi: 10.1016/j.ejca.2024.114129.

 

  1. Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast. 2024 Jul 4:77:103765. doi: 10.1016/j.breast.2024.103765.

 

  1. Alessandro Strusi, Giada Pinterpe, Chiara Ciccarese, Romina Rose Pedone, Michele Sarcina, Valeria Sardaro, Rachele Belletto, Angelo Totaro, Marco Racioppi, Rossana Berardi, Giampaolo Tortora, Roberto Iacovelli. Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer. Expert Rev Anticancer Ther. 2024 Jun 27:1-4. doi: 10.1080/14737140.2024.2370384.

 

  1. M C Cursano, A A Valsecchi, F Pantano, M Di Maio, G Procopio, A Berruti, F Bertoldo, M Tucci, U De Giorgi, D Santini; Meet-URO and AIOM experts. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies. ESMO Open. 2024 Jun 19;9(7):103484. doi: 10.1016/j.esmoop.2024.103484.

 

  1. E. G. Pizzutilo, A. G. Agostara, S. Oresti, D. Signorelli, S. Stabile, C. Lauricella, V. Motta, A. Amatu, L. Ruggieri, M. Brambilla, M. Occhipinti, C. Proto, R. Giusti, M. Filetti, C. Genova, G. Barletta, F. Gelsomino, C. Bennati, M. Siringo, G. R. Di Fazio, M. Russano, M. Montrone, E. Gariazzo, E. Roca, P. Bordi, A. Delmonte, A. Scimone, L. Belluomini, F. Mazzoni, A. Carta, G. Pelizzari, G. Viscardi, F. Morgillo, A. Gelibter, S. Gori, R. Berardi, D. Cortinovis, A. Ardizzon, S. M. Veronese, A. Sartore-Bianchi, L. G. Giannetta, G. Cerea & S. Siena. Activity of Osimertinib in non-small-cell lung cancer with uncommon epidermal growth factor receptor mutations: retrospective observational multicenter study (ARTICUNO). ESMO Open. 2024 Jun;9(6):103592. doi: 10.1016/j.esmoop.2024.103592. Epub 2024, Jun 14

 

  1. Joachim G Aerts, Robert Belderbos, Paul Baas, Arnaud Scherpereel, Koen Bezemer, Ilona Enninga, Rob Meijer, Marcella Willemsen, Rossana Berardi, Dean Fennell, Rene Kerstens, Robin Cornelissen, Jan P van Meerbeeck; DENIM team. Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study. Lancet Oncol. 2024 Jul;25(7):865-878. doi: 10.1016/S1470-2045(24)00191-8. Epub 2024 Jun 4. IF 41,6

 

  1. Federica Pecci, Luca Cantini, Valeria Cognigni, Fabiana Perrone, Giulia Mazzaschi, Veronica Agostinelli, Giulia Mentrasti, Elda Favari, Michele Maffezzoli, Alessio Cortellini, Francesca Rossi, Rebecca Chiariotti, Francesco Maria Venanzi, Giuseppe Lo Russo, Giulia Galli, Claudia Proto, Monica Ganzinelli, Francesca Tronconi, Francesca Morgese, Carla Campolucci, Marco Moretti, Arianna Vignini, Marcello Tiseo, Roberta Minari, Marco Luigi Bruno Rocchi, Sebastiano Buti, Rossana Berardi. Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study - The Oncologist, Volume 29, Issue 3, March 2024, Pages e372–e381, https://doi.org/10.1093/oncolo/oyad273.

 

  1. C. Proto, M. Ganzinelli, S. Manglaviti, M. Imbimbo, G. Galli, M. Marabese, F. Zollo, M. F. Alvisi, M. Perrino, N. Cordua, F. Borea, F. de Vincenzo, A. Chella, S. Cappelli, E. Pardini, Z. Ballatore, A. Lucarelli, E. Ambrosini, M. Giuliano, E. Pietroluongo, C. Mulargiu, A. Fabbri, A. Prelaj, M. Occhipinti, M. Brambilla, L. Mazzeo, T. Beninato, R. Vigorito, M. Ruggirello, F. G. Greco, G. Calareso, D. Miliziano, E.Rulli, I. De Simone, V. Torri, F. G. M. de Braud, G. Pasello, P. De Placido, R. Berardi, I. Petrini, P. Zucali, M. C. Garassino, G. Lo Russo. Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671). Ann Oncol. 2024 Jun 8:S0923-7534(24)00724-5. doi: 10.1016/j.annonc.2024.06.002.

 

  1. Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Rafaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud, Vincenzo Mazzaferro. Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

 

  1. Ondřej Fiala, Sebastiano Buti, Aristotelis Bamias, Francesco Massari, Renate Pichler, Marco Maruzzo, Enrique Grande, Ugo De Giorgi, Javier Molina-Cerrillo, Emmanuel Seront, Fabio Calabrò, Zin W Myint, Gaetano Facchini, Ray Manneh Kopp, Rossana Berardi, Jakub Kucharz, Maria Giuseppa Vitale, Alvaro Pinto, Luigi Formisano, Thomas Büttner, Carlo Messina, Fernando Sabino M Monteiro, Nicola Battelli, Ravindran Kanesvaran, Tomáš Büchler, Jindřich Kopecký, Daniele Santini, Giulia Claire Giudice, Camillo Porta, Matteo Santoni. Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study). Target Oncol. 2024 May 5. doi: 10.1007/s11523-024-01065-w. Online ahead of print.

 

  1. Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrik-Tobias Arkenau, Lajos Géczi, Javier Garcia-Corbacho, Luis G Paz-Ares, Syed A Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger de Speville. First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study. Cancer Res Commun. 2024 Apr 26. doi: 10.1158/2767-9764.CRC-23-0459. Online ahead of print.

 

  1. Francesco Massari, Matteo Santoni, Hideki Takeshita, Yohei Okada, Jose Carlos Tapia, Umberto Basso, Marco Maruzzo, Sarah Scagliarini, Thomas Büttner, Giuseppe Fornarini, Zin W. Myint, Luca Galli, Vinicius Carrera Souza, Renate Pichler, Ugo De Giorgi, Nathalia Gandur, Elaine T. Lam, Danielle Gilbert, Lazar Popovic, Enrique Grande, Giulia Mammone, Rossana Berardi, Simon J. Crabb, Robert Kemp, Javier Molina‑Cerrillo, Marcelo Freitas, Murilo Luz, Roberto Iacovelli, Fabio Calabrò, Deniz Tural, Francesco Atzori, Zsófa Küronya, Rita Chiari, Saul Campos, Orazio Cafo, André P. Fay, Jakub Kucharz, Paolo Andrea Zucali, José Augusto Rinck, Annalisa Zeppellini, Diogo Assed Bastos, Gaetano Aurilio, Augusto Mota, Karine Trindade, Cinzia Ortega, Juan Pablo Sade, Mimma Rizzo, Ondřej Fiala, Nuno Vau, Patrizia Giannatempo, Allan Barillas, Fernando Sabino M. Monteiro, Breno Dauster, Alessia Mennitto, Lucas Nogueira, Roni de Carvalho Fernandes, Emmanuel Seront, Luís Garcia Aceituno, Francesco Grillone, Hernan Javier Cutuli, Mauricio Fernandez, Maria Bassanelli, Ray Manneh Kopp. Giandomenico Roviello, Halima Abahssain, Giuseppe Procopio, Michele Milella, Jindrich Kopecky, Angelo Martignetti, Carlo Messina, Manuel Caitano, Eva Inman, Ravindran Kanesvaran, Daniel Herchhorn, Daniele Santini, Aristotelis Bamias, Renato Bisonni, Alessandra Mosca, Franco Morelli, Fernando Maluf, Andrey Soares, Fernando Nunes, Alvaro Pinto, Anca Zgura, Lorena Incorvaia, Jawaher Ansari, Ignacio Ortego Zabalza, Johannes Landmesser, Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, Matteo Rosellini, Giulia Sorgentoni, Nicola Battelli, Sebastiano Buti, Camillo Porta, Joaquim Bellmunt. Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w.

 

  1. Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Raffaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset, Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud, Vincenzo Mazzaferro. A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

 

 

  1. Alessandro Leonetti, Fabiana Perrone, Matteo Puntoni, Giuseppe Maglietta, Paola Bordi, Emilio Bria, Emanuele Vita, Francesco Gelsomino, Andrea De Giglio, Alain Gelibter, Marco Siringo, Francesca Mazzoni, Enrico Caliman, Carlo Genova, Federica Bertolini, Giorgia Guaitoli, Francesco Passiglia, Marco Donatello Delcuratolo, Michele Montrone, Giulio Cerea, Giulia Pasello, Elisa Roca, Lorenzo Belluomini, Fabiana Letizia Cecere, Annalisa Guida, Anna Manzo, Vincenzo Adamo, Francesca Rastelli, Alessandra Bulotta, Fabrizio Citarella, Luca Toschi, Federica Zoratto, Diego Luigi Cortinovis, Rossana Berardi, Alessandro Follador, Annamaria Carta, Andrea Camerini, Flavio Salerno, Rosa Rita Silva, Editta Baldini, Alessio Cortellini, Matteo Brighenti, Matteo Santoni, Francesco Malorgio, Caterina Caminiti, Marcello Tiseo. Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. Eur J Cancer. 2024 May:202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.

 

  1. Thomas Powles, Begoña P Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Jean Hoffman-Censits, Gopa Iyer, Christof Vulsteke, Se Hoon Park, Sang Joon Shin, Daniel Castellano, Giuseppe Fornarini, Jian-Ri Li, Mahmut Gümüş, Nataliya Mar, Yohann Loriot, Aude Fléchon, Ignacio Duran, Alexandra Drakaki, Sujata Narayanan, Xuesong Yu, Seema Gorla, Blanca Homet Moreno, Michiel S van der Heijden; EV-302 Trial Investigators. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117.

 

  1. Brigida Anna Maiorano, Massimo Di Maio, Linda Cerbone, Evaristo Maiello, Giuseppe Procopio, Giandomenico Roviello; MeetURO Group. Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Mar 4;7(3):e241215. doi: 10.1001/jamanetworkopen.2024.1215.

 

  1. R. Berardi, F. Rossi, R. Papa, M. Appetecchia, G. Baggio, M. Bianchini, T. Mazzei, A. Maria Moretti, E. Ortona, F. Pietrantonio, V. Tarantino, T. Vavalà & S. Cinieri. Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM). ESMO Open. 2024 Feb;9(2):102243. doi: 10.1016/j.esmoop.2024.102243. Epub 2024 Feb 23. IF 8,7

 

  1. Emilio Bria, Floriana Morgillo, Marina Chiara Garassino , Fortunato Ciardiello , Andrea Ardizzoni , Alessio Stefani , Francesco Verderame , Alessandro Morabito , Antonio Chella , GiuseppeTonini, Marina Gilli, Ester Del Signore, Rossana Berardi, Manlio Mencoboni, Alessandra Bearz, Angelo Delmonte, Marta Rita Migliorino, Cesare Gridelli, Antonio Pazzola, Manuela Iero, Filippo De Marinis, Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial - The Oncologist, 2024, XX, 1–9 https://doi.org/10.1093/oncolo/oyad342

 

  1. Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, Antoine Hollebecque, Jean Frederic Blanc, Mohamed Bouattour, Eric Assenat, Meher Ben Abdelghani, Matthieu Sarabi, Monica Niger, Caterina Vivaldi, Mario Mandalà, Andrea Palloni, Maria Bensi, Silvio Ken Garattini, David Tougeron, Pierre Combe, Massimiliano Salati, Margherita Rimini, Chiara Alessandra Cella, Marco Tucci, Anna Diana, Elena Mori, Raffaella Longarini, Pascal Artru, Gael Roth, Ludovic Evesque, Agathe Vienne, Anthony Turpin, Sandrine Hiret, Vincent Bourgeois, Camille Herve, Rodolphe Paulon, Marion Stacoffe, David Malka, Cindy Neuzillet, Julien Edeline, Astrid Lievre, Rosine Guimbaud, Marie Christelle Pajiep Chapda, Lorenza Rimassa, Riccardo Giampieri, Juan Valle, Rossana Berardi, Nadim Fares. Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies. Eur J Cancer. 2024 Mar;200:113587. doi: 10.1016/j.ejca.2024.113587. Epub 2024 Feb 6.

 

  1. Daniele Generali, Rossana Berardi, Michele Caruso, Marina Cazzaniga, Ornella Garrone, Ida Minchella, Ida Paris, Carmine Pinto and Sabino De Placido. Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions. Front. Oncol. 14:1369562. doi: 10.3389/fonc.2024.1369562

 

  1. Anna Vespa, Maria Velia Giulietti, Paolo Fabbietti, Mirko Di Rosa, Pisana Gattafoni, Rossana Berardi, Giorgio Arnaldi, Giancarlo Balercia and Roberta Spatuzzi. Using temperament and character dimensions (TCI) to analyze the personality profiles of adults and older adults with cancer managed in outpatient settings. Front. Psychol. 14:1289093. doi: 10.3389/fpsyg.2023.1289093
     
  2. Arsela Prelaj, Monica Ganzinelli, Leonardo Provenzano, Laura Mazzeo, Giuseppe Viscardi, Giulio Metro, Giulia Galli, Francesco Agustoni, Carminia Maria Della Corte, Andrea Spagnoletti, Claudia Giani, Roberto Ferrara, Claudia Proto, Marta Brambilla, Andra Diana Dumitrascu, Alessandro Inno, Diego Signorelli, Elio Gregory Pizzutilo, Matteo Brighenti, Federica Biello, Chiara Bennati, Luca Toschi, Marco Russano, Alessio Cortellini, Chiara Catania, Federica Bertolini, Rossana Berardi, Luca Cantini, Federica Pecci, Marianna Macerelli, Rita Emili, Claudia Bareggi, Francesco Verderame, Antonio Lugini, Salvatore Pisconti, Federica Buzzacchino, Michele Aieta, Alfredo Tartarone, Gianpaolo Spinelli, Emanuele Vita, Salvatore Grisanti, Francesco Trovò, Pietro Auletta, Daniele Lorenzini, Luca Agnelli, Sabina Sangaletti, Francesca Mazzoni, Giuseppina Calareso, Margherita Ruggirello, Gabriella Francesca Greco, Raffaella Vigorito, Mario Occhipinti, Sara Manglaviti, Teresa Beninato, Rita Leporati, Paolo Ambrosini, Roberta Serino, Cecilia Silvestri, Emanuela Zito, Alessandra Chiara Laura Pedrocchi, Vanja Miskovic, Filippo de Braud, Giancarlo Pruneri, Giuseppe Lo Russo, Carlo Genova, Andrea Vingiani. APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research. Clin Lung Cancer. 2024 Mar;25(2):190-195. doi: 10.1016/j.cllc.2023.12.012. Epub 2023 Dec 22.

 

  1. Francesco Panzuto, Stefano Partelli, Davide Campana, Filippo de Braud, Francesca Spada, Mauro Cives, Salvatore Tafuto, Alexia Bertuzzi, Fabio Gelsomino, Francesca Bergamo, Stefano Marcucci, Laura Mastrangelo, Sara Massironi, Marialuisa Appetecchia, Angelina Filice, Giuseppe Badalamenti, Mirco Bartolomei, Vito Amoroso, Luca Landoni, Maria Grazia Rodriquenz, Monica Valente, Annamaria Colao, Andrea Isidori, Giuseppe Fanciulli, Roberto Bollina, Michele Ciola, Giovanni Butturini, Riccardo Marconcini, Emanuela Arvat, Saverio Cinieri, Rossana Berardi, Sergio Baldari, Ferdinando Riccardi, Chiara Spoto, Dario Giuffrida, Domenico Gattuso, Diego Ferone, Maria Rinzivillo, Emilio Bertani, Annibale Versari, Alessandro Zerbi, Giuseppe Lamberti, Eleonora Lauricella, Sara Pusceddu, Nicola Fazio, Elisabetta Dell'Unto, Marco Marini, Massimo Falconi. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database. Endocrine. 2024 Apr;84(1):42-47. doi: 10.1007/s12020-023-03649-4. Epub 2024 Jan 4.

 

  1. Pietro Quaglino, Paolo Ascierto, Francesca Consoli, Paola Queirolo, Francesco Spagnolo, Maria Francesca Morelli, Rossana Berardi, Vanna Chiarion-Sileni, Marco Tucci, Teresa Troiani, Barbara Melotti, Ernesto Rossi, Mario Mandala, Gaetana Rinaldi, Ilaria Gioia Marcon, Matteo Pizzuti, Michele Del Vecchio. Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access - https://doi.org/10.2147/CMAR.S423970.

 

  1. Zelmira Ballatore, Amalia Goudas, Francesco Bozzi, Alessandra Lucarelli, Michela Burattini, Giulia Ricci, Francesco Savino, Rossana Berardi. A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic. Explor Target Antitumor Ther. 2023;4:793–800. Doi: 10.37349/etat.2023.00168

 

  1. Zelmira Ballatore, Francesco Bozzi, Sara Cardea, Francesco Domenico Savino, Antonella Migliore, Valentina Tarantino, Natalia Chiodi, Elisa Ambrosini, Francesca Bianchi, Gaia Goteri, Alessandra Filosa, Francesca Barbisan, Elisa Bartoli, Roberto Papa and Rossana Berardi. Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine - Medicine. J. Clin. Med. 2023, 12, 6666. https://doi.org/10.3390/ jcm12206666

 

  1. Alberto Giovanni Leone, Raffaella Casolino, Dario Trapani, Rosalba Miceli, Massimo Massagrande, Federica Morano, Nicla La Verde, Davide Dalu, Rossana Berardi, Silvia Marsoni, Matteo Lambertini, Bianca Iula, Eva Carieri, Manlio Converti, Massimo Di Maio, Giordano Domenico Beretta, Francesco Perrone, Filippo Pietrantonio, and Saverio Cinieri, on behalf of the Italian Foundation of Medical Oncology (Fondazione AIOM) Italian Association of Medical Oncology (AIOM). Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov.

 

 

  1. Veronica Agostinelli, Zelmira Ballatore, Giulia Ricci, Alessandra Lucarelli, Michela Burattini, Lorenzo Mariotti, Claudia Catani, Valentina Tarantino, Rossana Berardi. Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology. Explor Target Antitumor Ther. 2023;4:1095–103. https://doi.org/ 10.37349/etat.2023.00183

 

  1. Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, Vanda Salutari, Maria Vittoria Carbone, Viola Ghizzoni, Camilla Nero, Caterina Ricci, Maria Teresa Perri, Elena Giudice, Sara Lardino, Rossana Berardi, Giovanni Scambia, Domenica Lorusso. Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data - Cancer Manag Res. 2023 Sep 27:15:1063-1072. doi: 10.2147/CMAR.S294080. eCollection 2023.

 

  1. L. Incorvaia, G. Badalamenti, G. Novo, S. Gori, L. Cortesi, C. Brando, S. Cinieri, G. Curigliano, G. R. Ricciardi, A. Toss, R. Chiari, R. Berardi, Z. Ballatore, M. Bono, T. D. Bazan Russo, V. Gristina, A. Galvano, G. Damerino, L. Blasi, V. Bazan & A. Russo. Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).
    ESMO Open. 2024 Jan;9(1):102196.doi: 10.1016/j.esmoop.2023.102196. Epub 2023 Dec 19.

 

  1. Andrea Pretta, Pina Ziranu, Riccardo Giampieri, Giovanna Pinna, Giovanni Randon, Clelia Donisi, Alberto Ravarino, Francesco Loi, Giulia Deias, Enrico Palmas, Gianluca Pretta, Federica Morano, Francesca Semonella, Stefano Mariani, Maria Assunta Deidda, Valeria Pusceddu, Marco Puzzoni, Eleonora Lai, Cinzia Solinas, Angelo Restivo, Luigi Zorcolo, Raffaele Barbara, Rossana Berardi, Gavino Faa, Filippo Pietrantonio, Mario Scartozzi. Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy. Br J Cancer. 2023 Nov;129(10):1619-1624. doi: 10.1038/s41416-023-02444-2. Epub 2023 Sep 25.

 

  1. Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Yohei Okada, Francesco Massari, Georgia Anguera Palacios, Michele Dionese, Sarah Scagliarini, Thomas Büttner, Giuseppe Fornarini, Zin W Myint, Luca Galli, Vinicius Carrera Souza, Renate Pichler, Ugo De Giorgi, María Natalia Gandur Quiroga, Danielle Gilbert, Lazar Popovic, Enrique Grande, Giulia Mammone, Rossana Berardi, Simon J Crabb, Javier Molina-Cerrillo, Marcelo Freitas, Murilo Luz, Roberto Iacovelli, Fabio Calabrò, Deniz Tural, Francesco Atzori, Zsófia Küronya, Rita Chiari, Saul Campos, Orazio Caffo, André P Fay, Jakub Kucharz, Paolo Andrea Zucali, José Augusto Rinck, Annalisa Zeppellini, Diogo Assed Bastos, Gaetano Aurilio, Augusto Mota, Karine Trindade, Cinzia Ortega, Juan Pablo Sade, Mimma Rizzo, Nuno Vau, Patrizia Giannatempo, Allan Barillas, Fernando Sabino Marques Monteiro, Breno Dauster, Carlo Cattrini, Lucas Nogueira, Roni de Carvalho Fernandes, Emmanuel Seront, Luís Garcia Aceituno, Francesco Grillone, Hernan Javier Cutuli, Mauricio Fernandez, Maria Bassanelli, Giandomenico Roviello, Halima Abahssain, Giuseppe Procopio, Michele Milella, Jindrich Kopecky, Angelo Martignetti, Carlo Messina, Manuel Caitano, Eva Inman, Ravindran Kanesvaran, Daniel Herchenhorn, Daniele Santini, Ray Manneh, Renato Bisonni, Roubini Zakopoulou, Alessandra Mosca, Franco Morelli, Fernando Maluf, Andrey Soares, Fernando Nunes, Alvaro Pinto, Anca Zgura, Lorena Incorvaia, Jawaher Ansari, Ignacio Ortego Zabalza, Johannes Landmesser, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Nicola Battelli, Camillo Porta, Joaquim Bellmunt, Matteo Santoni. Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep 7.

 

  1. Chengzhi Zhou, Yinyin Qin, Wei Zhao, Zhenyu Liang, Min Li, Dan Liu, Li Bai, Yahong Chen, Yan Chen, Yuan Cheng, Tianqing Chu, Qian Chu, Haiyi Deng, Yuchao Dong, Wenfeng Fang, Xiuhua Fu, Beili Gao, Yiping Han, Yong He, Qunying Hong, Jie Hu, Yi Hu, Liyan Jiang , Yang Jin, Fen Lan, Qiang Li, Shuben Li , Wen Li, Yaqing Li, Wenhua Lian, Gen Lin, Xinqing Lin, Ming Liu, Xiaofang Liu, Xiaoju Liu, Zhefeng Liu, Tangfeng Lv, Chuanyong Mu, Ming Ouyang , Jianwen Qin, Shengxiang Ren, Huanzhong Shi, Minhua Shi, Chunxia Su, Jin Su, Dejun Sun, Yongchang Sun, Huaping Tang, Huijuan Wang, Kai Wang, Ke Wang, Mengzhao Wang, Qi Wang, Wei Wang, Xiaoping Wang, Yuehong Wang, Zhijie Wang, Zirui Wang , Lin Wu, Di Wu, Baosong Xie, Min Xie, Xiaohong Xie, Zhanhong Xie , Shufeng Xu, Xiaoman Xu, Xia Yang, Yan Yin, Zongyang Yu, Jian Zhang, Jianqing Zhang, Jing Zhang, Xiaoju Zhang, Yingying Zhang, Diansheng Zhong, Qing Zhou, Xiangdong Zhou, Yanbin Zhou, Bo Zhu, Zhengfei Zhu, Chenxi Zou , Nanshan Zhong , Jianxing He , Chunxue Bai, Chengping Hu, Weimin Li, Yong Song, Jianying Zhou, Baohui Han, Janos Varga, Esther Barreiro, Hye Yun Park, Francesco Petrella, Yuichi Saito, Taichiro Goto, Hitoshi Igai, Sara Bravaccini, Michele Zanoni, Piergiorgio Solli, Satoshi Watanabe, Alfonso Fiorelli, Takeo Nakada, Yoshinobu Ichiki, Rossana Berardi, Nikolaos Tsoukalas, Nicolas Girard, Antonio Rossi, Antonio Passaro, Toyoaki Hida, Shiyue Li, Liang’an Chen, Rongchang Chen. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. Transl Lung Cancer Res. 2023 Aug 30;12(8):1661-1701. doi: 10.21037/tlcr-23-339. Epub 2023 Aug 24.

 

  1. Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, Zin W Myint, Nicolò Cavasin, Roberto Iacovelli, Martin Pichler, Jindrich Kopecky, Jakub Kucharz, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo DE Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo A Zucali, Ray M Kopp, Giuseppe Fornarini, Maria T Bourlon, Sarah Scagliarini, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R Matrana, Renate Pichler, Carlo Cattrini, Tomáš Büchler, Francesco Massari, Veronica Mollica, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Orazio Caffo, Giuseppe Procopio, Kaisa Sunela, Maria Bassanelli, Cinzia Ortega, Francesco Grillone, Johannes Landmesser, Sara Merler, Carlo Messina, Zsófia Küronya, Alessandra Mosca, Dipen Bhuva, Daniele Santini, Nuno Vau, Franco Morelli, Lorena Incorvaia, Sara E Rebuzzi, Giandomenico Roviello, Andrey Soares, Ignacio O Zabalza, Alessandro Rizzo, Renato Bisonni, Francesco Pierantoni, Giulia Sorgentoni, Fernando S Monteiro, Nicola Battelli, Sebastiano Buti, Matteo Santoni. Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
    Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

 

  1. B.Trevisan , F. F. Pepe , I.Vallini, E. Montagna, D.Amoroso, R. Berardi, A. Butera, K. Cagossi , L. Cavanna, M. Ciccarese, S. Cinieri, E. Cretella, E. De Conciliis, A. Febbraro, F. Ferraù, A. Ferzi, A. Baldelli, A. Fontana, A. R.Gambaro, O.Garrone, V.Gebbia, D.Generali, L.Gianni, F.Giovanardi, A.Grassadonia, V. Leonardi, S. Sarti, A. Musolino, M. Nicolini, C. Putzu, F. Riccardi, D. Santini, M.G. Sarobba, M. G. Schintu, G. Scognamiglio, P. Spadaro, C.Taverniti, D.Toniolo, P.Tralongo, A.Turletti, R.Valenza, M. R.Valerio, P. Vici, L. Clivio, V.Torri, M. E. Cazzaniga & The VICTOR Study Group*. Final results of the real‑life observational VICTOR‑6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients. Nature, Scientifc Reports | (2023) 13:12255 | https://doi.org/10.1038/s41598-023-39386-x.

 

  1. Alessandro Parisi, Francesca Rossi, Chiara De Filippis, Francesco Paoloni, Cristiano Felicetti, Alex Mammarella, Federica Pecci, Alessio Lupi, Rossana Berardi. Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers. Onco Targets Ther. 2023 Jul 18;16:585-613. doi: 10.2147/OTT.S272563. eCollection 2023.

 

  1. Matteo Santoni, Sebastiano Buti, Zin, W. Myint, Marco Maruzzo, Roberto Iacovelli, Martin Pichler, Jindrich Kopecky, Jakub Kucharz, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Ray Manneh Kopp, Giuseppe Fornarini, Maria T. Bourlon t, Sarah Scagliarini u, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R. Matrana, Renate Pichler, Carlo Cattrini, Tomas Büchler, Francesco Massari, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Aristotelis Bamias, Orazio Caffo, Giuseppe Procopio, Kaisa Sunela, Maria Bassanelli, Cinzia Ortega, Francesco Grillone, Johannes Landmesser, Michele Milella, Carlo Messina, Zsófia Küronya Alessandra Mosca, Dipen Bhuva, Daniele Santini, Nuno Vau, Franco Morelli, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Andrey Soares, Renato Bisonni, Davide Bimbatti Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Fernando Sabino M. Monteiro, Nicola Battelli, Sergio Bracarda, Camillo Porta. Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? EUROPEAN UROLOGY ONCOLOGY 7 (2024) 102–111. https://doi.org/10.1016/j.euo.2023.07.003

 

  1. Riccardo Giampieri, Maria Giuditta Baleani, Alessandro Bittoni, Francesca Rastelli, Vincenzo Catalano, Michela Del Prete, Silvia Chiorrini, Giada Pinterpe, Francesco Graziano, Francesca Chiara Giorgi, Renato Bisonni, Rosarita Silva, Paolo Alessandroni, Lara Mencarini, and Rossana Berardi. Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy. - Cancers 2023, 15, 3342. https://doi.org/10.3390/cancers15133342

 

  1. Carmine Valenza, Dario Trapani, Sara Gandini, Caterina Sposetti, Luca Boscolo Bielo, Antonio Marra, Tommaso Giarratano, Diletta Favero, Laura Cortesi, Luca Moscetti, Mirco Pistelli, Rossana Berardi, Alberto Zambelli, Matteo Lambertini, Lucia Del Mastro, Valentina Guarneri, Claudio Vernieri, Giuseppe Curigliano. Platinum-base chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments. Eur J Cancer. 2023 Sep:190:112944.doi: 10.1016/j.ejca.2023.112944. Epub 2023 Jun 20.

 

  1. Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindrich Kopecky, Jakub Kucharz, Sebastiano Buti, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Giuseppe Fornarini, Maria T Bourlon, Sarah Scagliarini, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R Matrana, Renate Pichler, Carlo Cattrini, Tomas Büchler, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Aristotelis Bamias, Orazio Caffo, Giuseppe Procopio, Maria Bassanelli, Sara Merler, Carlo Messina, Zsófia Küronya, Alessandra Mosca, Dipen Bhuva, Nuno Vau, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Fernando Sabino M Monteiro, Rodolfo Montironi, Nicola Battelli, Camillo Porta. Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study. Target Oncol. 2023 Jul;18(4):559-570.doi: 10.1007/s11523-023-00978-2. Epub 2023 Jun 27.

 

  1. Nicoletta Colombo, Angiolo Gadducci, Fabio Landoni, Domenica Lorusso, Roberto Sabbatini, Grazia Artioli, Rossana Berardi, Rita Ceccherini, Sabrina Chiara Cecere, Gennaro Cormio, Carmine De Angelis, Francesco Legge, Andrea Lissoni, Serafina Mammoliti, Giorgia Mangili, Emanuele Naglieri, Maria Cristina Petrella, Giuseppina Rosaria Rita Ricciardi, Graziana Ronzino, Vanda Salutari, Daniela Sambataro, Antonella Savarese, Giuseppa Scandurra, Giulia Tasca, Federica Tomao, Giorgio Valabrega, Laura Zavallone, Sandro Pignata. Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study. Gynecol Oncol. 2023 Aug:175:182-189.doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22.

 

  1. Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Katia Cannita, Ugo De Giorgi, Fulvio Borella, Jennifer Foglietta, Anna Cariello, Antonella Ferro, Elisa Picardo, Marco Mitidieri, Valentina Sini, Simonetta Stani, Giuseppe Tonini, Daniele Santini, Nicla La Verde, Anna Rita Gambaro, Antonino Grassadonia, Nicola Tinari, Ornella Garrone, Giuseppina Sarobba, Lorenzo Livi, Icro Meattini, Giuliana D’Auria, Matteo Vergati, Teresa Gamucci, Mirco Pistelli, Rossana Berardi, Emanuela Risi, Francesco Giotta, Vito Lorusso, Lucia Rinaldi, Salvatore Artale, Marina Elena Cazzaniga, Fable Zustovich, Federico Cappuzzo, Lorenza Landi, Rosalba Torrisi, Simone Scagnoli, Andrea Botticelli,  Andrea Michelotti, Beatrice Fratini, Rosa Saltarelli, Ida Paris, Margherita Muratore, Alessandra Cassano, Lorenzo Gianni, Valeria Gaspari, Enzo Maria Veltri, Federica Zoratto, Elena Fiorio, Maria Agnese Fabbri, Marco Mazzotta, Enzo Maria Ruggeri, Rebecca Pedersini, Maria Rosaria Valerio, Lorena Filomeno, Mauro Minelli, Paola Scavin, Mimma Raffaele, Antonio Astone, Roy De Vita, Marcello Pozzi, Ferdinando Riccardi, Filippo Greco, Luca Moscetti, Monica Giordano, Marcello Maugeri-Saccà, Alessandro Zennaro, Claudio Botti, Fabio Pelle, Sonia Cappelli, Flavia Cavicchi, Enrico Vizza, Giuseppe Sanguineti, Federica Tomao, Enrico Cortesi, Paolo Marchetti, Silverio Tomao, Iolanda Speranza, Isabella Sperduti, Gennaro Ciliberto and Patrizia Vici. Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study. Front. Oncol. 13:1152123. doi: 10.3389/fonc.2023.1152123

 

  1. Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni, Mariangela Torniai, Elisa Andrini, Dario de Biase, Deborah Malvi, Mirta Mosca, Rossana Berardi, Toni Ibrahim, Sara Pusceddu and Davide Campana. Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). Diagnostics 2023, 13, 1595. https://doi.org/10.3390/ diagnostics13091595.

 

  1. Nicola Normanno, Antonella De Luca, Riziero Esposito Abate, Alessandro Morabito, Michele Milella, Fabrizio Tabbò, Giuseppe Curigliano, Cristina Masini, Paolo Marchetti, Giancarlo Pruneri, Valentina Guarneri, Giovanni L. Frassineti, Gianpiero Fasola, Vincenzo Adamo, Bruno Daniele, Rossana Berardi, Florinda Feroce, Evaristo Maiello, Carmine Pinto. Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study.  Eur J Cancer. 2023 Jul:187:174-184. doi: 10.1016/j.ejca.2023.03.027.

 

  1. Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, Marco Musca, Giulia Galli, Martina Imbimbo, Matteo Perrino, Nadia Cordua, Eliana Rulli, Zelmira Ballatore, Alessandro Dal Maso, Antonio Chella, Andrea Sbrana, Arsela Prelaj, Roberto Ferrara, Mario Occhipinti, Marta Brambilla, Alessandro De Toma, Laura Mazzeo, Teresa Beninato, Diego Signorelli, Giacomo Massa, Francesca Gabriella Greco, Giuseppina Calareso, Daniela Miliziano, Rosa Maria Di Mauro, Giulia Mella, Alessandra Lucarelli, Angela Paggio, Francesca Galli, Valter Torri, Filippo Guglielmo Maria de Braud, Giulia Pasello, Iacopo Petrini, Rossana Berardi, Monica Ganzinelli, Marina Chiara Garassino, Paolo Andrea Zucali. STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines. J Thorac Oncol. 2023 Aug;18(8):1070-1081.doi: 10.1016/j.jtho.2023.04.009.

 

  1. Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindrich Kopecky, Jakub Kucharz, Sebastiano Buti, Alessia Salfi, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique GrandE, Paolo Andrea Zucali, Giuseppe Fornarini, Maria T Bourlon, Sarah Scagliarini, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R Matrana, Renate Pichler, Carlo Cattrini, Tomas Büchler, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Roubini Zakopoulou, Orazio Caffo, Giuseppe Procopio, Maria Bassanelli, Ilaria Zampiva, Carlo Messina, Zsófia Küronya, Alessandra Mosca, Dipen Bhuva, Nuno Vau, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Ilaria Catalini, Fernando Sabino M Monteiro, Rodolfo Montironi, Nicola Battelli, Mimma Rizzo, Camillo Porta. Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1). Clin Genitourin Cancer. 2023 Oct;21(5):e309-e319.e1. doi: 10.1016/j.clgc.2023.03.006. Epub 2023 Mar 20.

 

  1. Luca Cantini, Francesco Paoloni, Federica Pecci, Francesco Spagnolo, Carlo Genova, Enrica Teresa Tanda, Sophie Aerts, Bsc, Sara Elena Rebuzzi, Giuseppe Fornarini, Federica Zoratto, Sara Fancelli, Alessio Lupi, Carminia Maria Della Corte, Alessandro Parisi, Chiara Bennati, Cinzia Ortega, Francesco Atzori, Pier Luigi Piovano, Corrado Orciuolo, Michele De Tursi, Michele Ghidini, Andrea Botticelli, Simone Scagnoli, Lorenzo Belluomini, Rita Leporati, Antonello Veccia, Anna Maria Di Giacomo, Lucia Festino, Diego Cortinovis, Mirko Acquati, Marco Filetti, Raffaele Giusti, Marco Tucci, Maria Chiara Sergi, Mattia Garutti, Fabio Puglisi, Sara Manglaviti, Fabrizio Citarella, Matteo Santoni, Erika Rijavec, Giuseppe Lo Russo, Daniele Santini, Alfredo Addeo, Lorenzo Antonuzzo, Alice Indini, Marco Bruno Luigi Rocchi, Msc, Alessio Cortellini, Francesco Grossi, Paolo Antonio Ascierto, Joachim G J V Aerts, Rossana Berardi, Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort studyMD Author Notes JNCI: Journal of the National Cancer Institute, djad061. https://doi.org/10.1093/jnci/djad061 IF 9,9

 

  1. Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro and Nicla La Verde. Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. Int. J. Mol. Sci. 2023, 24, 4974. https://doi.org/ 10.3390/ijms24054974.

 

  1. Alessio Cortellini, Josep Tabernero, Uma Mukherjee, Ramon Salazar, Anna Sureda, Clara Maluquer, Daniela Ferrante, Mark Bower, Rachel Sharkey, Oriol Mirallas, Andrea Plaja, Marc Cucurull, Ricard Mesia, Alessia Dalla Pria, Thomas Newsom-Davis, Mieke Van Hemelrijck, Ailsa Sita-Lumsden, Eleanor Apthorp, Bruno Vincenzi, Giuseppina Rita Di Fazio, Giuseppe Tonini, Francesco Pantano, Alexia Bertuzzi, Sabrina Rossi, Joan Brunet, Matteo Lambertini, Paolo Pedrazzoli, Federica Biello, Francesca D’Avanzo, Alvin J X Lee, Marianne Shawe-Taylor, Lucy Rogers, Cian Murphy, Lee Cooper, Ramis Andaleeb, Saira Khalique, Samira Bawany, Sarah Ahmed, M Carmen Carmona-García, Roser Fort-Culillas, Raquel Liñan, Federica Zoratto, Gianpiero Rizzo, Marta Perachino, Kris Doonga, Gianluca Gaidano, Riccardo Bruna, Andrea Patriarca, Clara Martinez-Vila, Ignacio Pérez Criado, Raffaele Giusti, Francesca Mazzoni, Lorenzo Antonuzzo, Armando Santoro, Alessandro Parisi, Paola Queirolo, Avinash Aujayeb, Lorenza Rimassa, Nikolaos Diamantis, Rossella Bertulli, Claudia A M Fulgenzi, Antonio D’Alessio, Isabel Ruiz-Camps, Nadia Saoudi-Gonzalez, David Garcia Illescas, Irene Medina, Laura Fox, Alessandra Gennari, Juan Aguilar-Company, David J Pinato, on behalf of the OnCovid study group. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. Lancet Oncol. 2023 Apr;24(4):335-346. doi: 10.1016/S1470-2045(23)00056-6.

 

  1. Joris van de Haar, Xuhui Ma, Salo N Ooft, Pim W van der Helm, Louisa R Hoes, Sara Mainardi, David J Pinato, Kristi Sun, Lisa Salvatore, Giampaolo Tortora, Ina Valeria Zurlo, Silvana Leo, Riccardo Giampieri, Rossana Berardi, Fabio Gelsomino, Valeria Merz, Federica Mazzuca, Lorenzo Antonuzzo, Gerardo Rosati, Chara Stavraka, Paul Ross, Maria Grazia Rodriquenz, Michele Pavarana, Carlo Messina, Timothy Iveson, Federica Zoratto, Anne Thomas, Elisabetta Fenocchio, Margherita Ratti, Ilaria Depetris, Massimiliano Cergnul, Cristina Morelli, Michela Libertini, Alessandro Parisi, Michele De Tursi, Nicoletta Zanaletti, Ornella Garrone, Janet Graham, Raffaella Longarini, Stefania Maria Gobba, Angelica Petrillo, Emiliano Tamburini, Nicla La Verde, Fausto Petrelli, Vincenzo Ricci, Lodewyk F A Wessels, Michele Ghidini, Alessio Cortellini, Emile E Voest, Nicola Valeri. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. IF 58,7

 

  1. Francesca Morgese, Francesco De Feudis, Paolo Balercia and Rossana Berardi. Potential dual synergy between electrochemotherapy and sequence of immunotherapies in metastatic melanoma: A case report. Molecular And Clinical Oncology 18: 8, 2023. DOI: 10.3892/mco.2023.2604

 

  1. Alberto Giovanni Leone, Dario Trapani, Matthew B. Schabath, Joshua D. Safer, N. F.N. Scout, Matteo Lambertini, Rossana Berardi, Silvia Marsoni, Francesco Perrone, Saverio Cinieri, Rosalba Miceli, Federica Morano, Filippo Pietrantonio. Cancer in Transgender and Gender-Diverse Persons A Review. JAMA Oncol. Published online February 9, 2023. doi:10.1001/jamaoncol.2022.7173

 

  1. M Reni, E Giommoni, F Bergamo, M Milella, L Cavanna, M C Di Marco, M Spada, S Cordio, G Aprile, G G Cardellino, E Maiello, I Bernardini, M Ghidini, S Bozzarelli, M Macchini, G Orsi, I De Simone, Er Rulli, L Porcu, V Torri, C Pinto; GARIBALDI Study Group. Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1 (collaborators).

 

  1. Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramon Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar-Company, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J X Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Alessandro Parisi, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H Lyman, Nicole M Kuderer, David J Pinato, Alessio Cortellini; OnCovid Study Group. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. J Clin Oncol 2023 May 20;41(15):2800-2814. doi: 10.1200/JCO.22.01667. IF 45,3

 

  1. Francesca Morgese, Valeria Cognigni, Laura Scortichini, Nicoletta Ranallo, Valentina Lunerti, Antonella Migliore, Francesca Tronconi and Rossana Berardi. Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma. Molecular And Clinical Oncology 18: 2, 2023. Received April 7, 2022; Accepted July 27, 2022. DOI: 10.3892/mco.2022.2598.

 

  1. Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Jordan Winter, Do-Youn Oh, Chung-Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D. Lopez, Tanios Bekaii-Saab, Andrew H. Ko, Armando Santoro, Joon Oh Park, Marcus S. Noel, Giovanni Luca Frassineti, Yan-Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan Berlin, Philip Philip, Malcolm Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, MD, Andrew V. Biankin and Michele Reni, on behalf of the APACT Investigators. Adjuvant nab-Paclitaxel 1 Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. J Clin Oncol. 2023 Apr 10;41(11):2007-2019. doi: 10.1200/JCO.22.01134. Epub 2022 Dec 15. (collaborator)

 

  1. Anna Vespa, Maria Velia Giulietti, Pisana Gattafoni, Paolo Fabbietti, Rossana Berardi, Giorgio Arnaldi, Giancarlo Balercia, Gianmaria Salvio, Marcello Ricciuti, Roberta Spatuzzi. Psychometric properties of the Italian version of the Revised Temperament and Character Inventory (TCI-140) in adults and older adults with cancer managed in outpatient settings. Journal of Geriatric Oncology, 14 (2023) 101416 https://doi.org/10.1016/j.jgo.2022.12.004

 

  1. Carolina Liguori, Cecilia Copparoni, Cristiano Felicetti, Federica Pecci, Alessio Lupi, Giada Pinterpe, Rossana Berardi and Riccardo Giampieri. Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study. Curr. Oncol. 2023, 30, 1032–1045. https://doi.org/ 10.3390/curroncol30010079.

 

  1. Fabio Conforti, Laura Pala, Grazia Vivanet, Chiara Corti, Chiara Catania, Daniele Maiettini, Gianluca Varano, Benedetta Di Venosa, Giuseppe Curigliano, Piermario Salvini, Rossana Berardi, Zelmira Ballatore, Tommaso Martino De Pas. High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study. Lung Cancer, 176 (2023) 98-102, https://doi.org/10.1016/j.lungcan.2023.01.004.

 

  1. Andrea Pretta, Pina Ziranua, Riccardo Giampieri, Clelia Donisi, Erika Cimbro, Dario Spanua, Eleonora Lai, Federica Pecci, Francesca Balconi, Alessio Lupi, Marta Pozzari, Mara Persano, Sara Murgia, Valeria Pusceddu, Marco Puzzoni, Rossana Berardi, Mario Scartozzi. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease, 2022 https://doi.org/10.1016/j.dld.2022.11.012.

 

  1. Stefano Granieri, Christian Cotsoglou, Alessandro Bonomi, Lisa Salvatore, Roberto Filippi, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Ilaria Depetris, Riccardo Giampieri, Rossana Berardi, Cristina Morelli, Michele De Tursi, Michela Roberto, Elson Gjoni, Alessandro Germini, Nicola de Angelis, Riccardo Memeo, Antonio Facciorusso, Ornella Garrone, Daryl Ramai, Michele Ghidini, and Alessandro Parisi. Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study. Cancers 2022, 14, 5513. https://doi.org/10.3390/ cancers14225513.

 

  1. Francesca Tronconi, Camilla Nero, Elena Giudice, Vanda Salutari, Lucia Musacchio, Caterina Ricci, Maria Vittoria Carbone, Viola Ghizzoni, Maria Teresa Perri, Floriana Camarda, Marica Gentile, Rossana Berardi, Giovanni Scambia, Domenica Lorusso. Advanced and recurrent endometrial cancer: State of the art and future perspectives. Critical Reviews in Oncology / Hematology, October 2022, https://doi.org/10.1016/j.critrevonc.2022.103851

 

  1. Pippa Corrie, Nicolas Meyer, Rossana Berardi, Massimo Guidoboni, Max Schlueter, Spyros Kolovos, Bérengère Macabeo, Jean-Baptiste Trouiller, Philippe Laramée. Response to considerations regarding a network meta-analysis of targeted therapies for BRAF mutant unresectable or metastatic melanoma. Cancer Treatment reviews, 2022 DOI: https://doi.org/10.1016/j.ctrv.2022.102478

 

  1. Valeria Cognigni, Federica Pecci, Alessio Lupi, Giada Pinterpe, Chiara De Filippis, Cristiano Felicetti, Luca Cantini and Rossana Berardi. The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives. Cancers 2022, 14, 4765. https://doi.org/10.3390/ cancers14194765. IF 5,2

 

  1. Corrie Pippa, Meyer Nicolas, Berardi Rossana, Guidoboni Massimo, Schlueter Maximilian, Kolovos Spyros, Macabeo Bérengère, Trouiller Jean-Baptiste, Laramée Philippe. Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis. Cancer Treatment Reviews Cancer Treatment Reviews (2022). doi: https://doi.org/10.1016/j.ctrv.2022.102463

 

  1. Agostinelli Veronica, Cognigni Valeria, Lunerti Valentina, Cicoli Camilla, Ricci Giulia, Papa Roberto, Caporossi Michele, Berardi Rossana. Diagnostic and therapeutic care pathways of cancer patients: A model of multidisciplinary management and patient-tailored healthcare at University Hospital in Italy. Hospital Administration and Medical Practices (2022) pages 1-7. https://doi.org/10.54844/hamp.2022.0027.

 

  1. D. Ciardiello, C. Chiarazzo, V. Famiglietti, A. Damato, C. Pinto, M. G. Zampino, G. Castellano, L. Gervaso, A. Zaniboni, E. Oneda, S. Rapisardi, R. Bordonaro, C. Zichi, F. De Vita, M. Di Maio, A. Parisi, R. Giampieri, R. Berardi, D. Lavacchi, L. Antonuzzo, E. Tamburini, B. A. Maiorano, P. Parrella, T. P. Latiano, N. Normanno, A. De Stefano, A. Avallone, G. Martini, S. Napolitano, T. Troiani, E. Martinelli, F. Ciardiello, F. De Vita, E. Maiello. Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM). ESMO Open, Volume 7 - Issue 5 - 2022 https://doi.org/10.1016/j.esmoop.2022.100567

 

  1. Giulia Mentrasti, LucaCantini, PatriziaVici, Nicola D'Ostilio, Nicla La Verde, Rita Chiari, Vittorio Paolucci Sonia Crocetti, Chiara De Filippis, Federica Pecci, Francesca Sofia Di Lisa, Donatella Traisci, Maria Silvia Cona, Linda Nicolardi, Laura Pizzuti, Simona Gildetti, Simone Oldani, Arianna Della Mora, Marco Luigi Bruno Rocchi, Rossana Berardi. Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study. The Breast Volume 65, October 2022, Pages 164-171https://doi.org/10.1016/j.breast.2022.08.007

 

  1. Federica Pecci, Luca Cantini, Giulio Metro, Biagio Ricciuti, Giuseppe Lamberti, Ammad Ahmad Farooqi, Rossana Berardi. Non-small-cell lung cancer: how to manage EGFR-mutated disease. Drugs Context. 2022;11:2022-4-1. https://doi.org/10.7573/dic.2022-4-1. ISSN: 1740-4398

 

  1. Giulia Mentrasti, Luca Cantini, Clizia Zichi, Nicola D’Ostilio, Fabio Gelsomino, Erika Martinelli, Rita Chiari, Nicla La Verde, Renato Bisonni, Valeria Cognigni, Giada Pinterpe, Federica Pecci, Antonella Migliore, Giacomo Aimar, Francesca De Vita, Donatella Traisci, Andrea Spallanzani, Giulia Martini, Linda Nicolardi, Maria Silvia Cona, Maria Giuditta Baleani, Marco Luigi Bruno Rocchi, Rossana Berardi. Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study. The Oncologist, 2022, 27, e723–e730 https://doi.org/10.1093/oncolo/oyac129

 

  1. Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita, Laura Mercatali, Chiara Calabrese, Chiara Spadazzi, Carlo Fabbri, Davide Cavaliere, Riccardo Galass, Stefano Severi, Maddalena Sansovini, Andreas Tartaglia, Federica Pieri, Laura Crudi, David Bianchini, Domenico Barone, Giovanni Martinelli, Giovanni Luca Frassineti, Toni Ibrahim, Luana Calabrò, Rossana Berardi and Alberto Bongiovanni. Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis. Cancers 2022, 14, 3231. https://doi.org/ 10.3390/cancers14133231

 

  1. Mariangela Torniai, Veronica Agostinelli, Luca Cantini, Carolina Liguori, Francesca Morgese, Silvia Rinaldi, Laura Scortichini, Rossana Berardi. Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows. Explor Target Antitumor Ther. 2022;3:321-36. https://doi.org/10.37349/etat.2022.00085.

 

 

  1. Veronica Agostinelli, Chiara De Filippis, Mariangela Torniai, Marco Rocchi, Alessandra Pagliacci, Giulia Ricci, Rosina Corsi, Paolo Luzi, Michele Caporossi, Rossana Berardi. Primum Non Nocere: how to assure the preserving continuum of care and to prevent cancer patients of being left aside during COVID-19 emergency. Cancer Medicine, Cancer Med. 2023 Jan;12(2):1821-1828. doi: 10.1002/cam4.4986. Epub 2022 Jun 27.

 

  1. Giuseppe L. Banna, Marcello Tiseo, Diego L. Cortinovis, Francesco Facchinetti, Joachim G. J. V. Aerts, Cinzia Baldessari, Raffaele Giusti, Emilio Bria, Francesco Grossi, Rossana Berardi, Alessandro Morabito, Annamaria Catino, Carlo Genova, Francesca Mazzoni, Alain Gelibter, Francesca Rastelli, Marianna Macerelli, Rita Chiari, Stefania Gori, Giovanni Mansueto, Fabrizio Citarella, Luca Cantini, Erika Rijavec, Federica Bertolini, Federico Cappuzzo, Alessandro De Toma, Alex Friedlaender, Giulio Metro, Maria Vittoria Pensieri, Giampiero Porzio, Corrado Ficorella, David J. Pinato, Alessio Cortellini, Alfredo Addeo. Host immune-inflammatory markers to unravel the heterogeneousoutcome and assessment of patients with PD-L1≥50% metastaticnon-small cell lung cancer and poor performance status receivingfirst-line immunotherapy. Thorac Cancer. 2021;1–6.https://doi.org/10.1111/1759-7714.14256.

 

  1. Rukset Attar, Tahira Panah, Mirna Azalea Romero, Ishmuratova Margarita Yulaevna, Maria Gazouli, Rossana Berardi, Edyta Wieczorek, Ammad Ahmad Farooqi. Overview of the signaling pathways involved in metastasis: An intriguing story-tale of the metastatic journey of ovarian cancer cells. Cell Mol Biol (Noisy-le-grand). 2021 Nov 25;67(3):212-223. doi: 10.14715/cmb/2021.67.3.34.

 

  1. OnCovid Study Group; David J Pinato, Meera Patel, Lorenza Scotti, Emeline Colomba, Saoirse Dolly, Angela Loizidou, John Chester, Uma Mukherjee, Alberto Zambelli, Alessia Dalla Pria, Juan Aguilar-Company, Mark Bower, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Matteo Lambertini, Marco Tagliamento, Anna Pous, Ailsa Sita-Lumsden, Krishnie Srikandarajah, Johann Colomba, Fanny Pommeret, Elia Seguí, Daniele Generali, Salvatore Grisanti, Paolo Pedrazzoli, Gianpiero Rizzo, Michela Libertini, Charlotte Moss, Joanne S Evans, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Federica Biello, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Sabrina Rossi, M Carmen Carmona-García, Carlo Tondini, Laura Fox, Alice Baggi, Vittoria Fotia, Alessandro Parisi, Giampero Porzio, Paola Queirolo, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué Lloveras, Thomas Newsom-Davis, Rachel Sharkey, Elisa Roldán, Roxana Reyes, Federica Zoratto, Irina Earnshaw, Daniela Ferrante, Javier Marco-Hernández, Isabel Ruiz-Camps, Gianluca Gaidano, Andrea Patriarca, Riccardo Bruna, Anna Sureda, Clara Martinez-Vila, Ana Sanchez de Torre, Rossana Berardi, Raffaele Giusti, Francesca Mazzoni, Annalisa Guida, Lorenza Rimassa, Lorenzo Chiudinelli, Michela Franchi, Marco Krengli, Armando Santoro, Aleix Prat, Josep Tabernero, Mieke Van Hemelrijck, Nikolaos Diamantis, Alessandra Gennari, Alessio Cortellini. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.

 

  1. Laia Garrigós, Cristina Saura, Clara Martinez-Vila, Alberto Zambelli, Mark Bower, Barbara Pistilli, Matteo Lambertini, Diego Ottaviani, Nikolaos Diamantis, Ailsa Lumsden, Sonia Pernas, Daniele Generali, Elia Seguí, Gemma Viñas, Eudald Felip, Ana Sanchez, Gianpiero Rizzo, Armando Santoro, Alessio Cortellini, Ylenia Perone, John Chester, Maria Iglesias, Marta Betti, Bruno Vincenzi, Michela Libertini, Francesca Mazzoni, Federica Zoratto, Rossana Berardi, Annalisa Guida, Rachel Wuerstlein, Angela Loizidou, Rachel Sharkey, Juan Aguilar Company, Marta Matas, Chiara Saggia, Lorenzo Chiudinelli, Emeline Colomba-Blameble, Myria Galazi, Uma Mukherjee, Mieke Van Hemelrijck, Mar Marin, Carla Strina, Aleix Prat, Helena Pla, Eva Maria Ciruelos, Alexia Bertuzzi, Lucia Del Mastro, Giampiero Porzio, Thomas Newsom-Davis, Isabel Ruiz, Maria Belen Delany, Marco Krengli, Vittoria Fotia, Alessandro Viansone, Neha Chopra, Margarita Romeo, Ramon Salazar, Ignacio Perez, Francesca d'Avanzo, Michela Franchi, Manuela Milani, Fanny Pommeret, Marco Tucci, Paolo Pedrazzoli, Nadia Harbeck, Daniela Ferrante, David J Pinato, Alessandra Gennari. COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. Ther Adv Med Oncol. 2021 Nov 2;13:17588359211053416. doi: 10.1177/17588359211053416. eCollection 2021.

 

  1. Valentina Natalucci, Francesco Lucertini, Luciana Vallorani, Giorgio Brandi, Manuela Marchegiani, Mirco Pistelli, Rossana Berardi, Maria Gabriella Ceravolo, Elena Barbieri, Marianna Capecci. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study. Heliyon. 2021 Oct 27;7(11):e08252. doi: 10.1016/j.heliyon.2021.e08252. eCollection 2021 Nov.

 

  1. David J Pinato, Josep Tabernero, Mark Bower, Lorenza Scotti, Meera Patel, Emeline Colomba, Saoirse Dolly, Angela Loizidou, John Chester, Uma Mukherjee, Alberto Zambelli, Alessia Dalla Pria, Juan Aguilar-Company, Diego Ottaviani, Amani Chowdhury, Eve Merry, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Matteo Lambertini, Marco Tagliamento, Anna Pous, Ailsa Sita-Lumsden, Krishnie Srikandarajah, Johann Colomba, Fanny Pommeret, Elia Seguí, Daniele Generali, Salvatore Grisanti, Paolo Pedrazzoli, Gianpiero Rizzo, Michela Libertini, Charlotte Moss, Joanne S Evans, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Federica Biello, Rossella Bertulli, Raquel Liñan, Sabrina Rossi, Maria Carmen Carmona-García, Carlo Tondini, Laura Fox, Alice Baggi, Vittoria Fotia, Alessandro Parisi, Giampero Porzio, Maristella Saponara, Claudia Andrea Cruz, David García-Illescas, Eudald Felip, Ariadna Roqué Lloveras, Rachel Sharkey, Elisa Roldán, Roxana Reyes, Irina Earnshaw, Daniela Ferrante, Javier Marco-Hernández, Isabel Ruiz-Camps, Gianluca Gaidano, Andrea Patriarca, Riccardo Bruna, Anna Sureda, Clara Martinez-Vila, Ana Sanchez de Torre, Luca Cantini, Marco Filetti, Lorenza Rimassa, Lorenzo Chiudinelli, Michela Franchi, Marco Krengli, Armando Santoro, Aleix Prat, Mieke Van Hemelrijck, Nikolaos Diamantis, Thomas Newsom-Davis, Alessandra Gennari, Alessio Cortellini, OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021 Dec;22(12):1669-1680.doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3.

 

  1. Riccardo Giampieri*, Alessio Lupi, Pina Ziranu, Alessandro Bittoni, Andrea Pretta, Federica Pecci, Mara Persano, Enrica Giglio, Cecilia Copparoni, Sonia Crocetti, Alessandra Mandolesi, Gavino Faa, Pierpaolo Coni, Mario Scartozzi and Rossana Berardi. Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab. Front. Oncol. 11:736104. doi: 10.3389/fonc.2021.736104.

 

  1. Alessandro Bittoni, Riccardo Giampieri, Federica Pecci, Giada Pinterpe, Alessandra Mandolesi, Michela Del Prete, Antonio Zizzi, Sonia Crocetti, Carolina Liguori, Giulia Mentrasti, Luca Cantini, Chiara Pellei, Renato Bisonni, Marina Scarpelli and Rossana Berardi*. Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Curr. Oncol. 2021, 28, 3525–3536. https://doi.org/10.3390/ curroncol28050303.

 

  1. M E Cazzaniga, I Vallini, E Montagna, D Amoroso, R Berardi, A Butera, K Cagossi, L Cavanna, M Ciccarese, S Cinieri, E Cretella, E De Conciliis, A Febbraro, F Ferraù, A Ferzi, A Baldelli, A Fontana, A R Gambaro, O Garrone, V Gebbia, D Generali, L Gianni, F Giovanardi, A Grassadonia, V Leonardi, P Marchetti, S Sarti, A Musolino, M Nicolini, C Putzu, F Riccardi, D Santini, S Saracchini, M G Sarobba, M G Schintu, G Scognamiglio, P Spadaro, C Taverniti, D Toniolo, P Tralongo, A Turletti, R Valenza, M R Valerio, P Vici, P Di Mauro, V Cogliati, S Capici, L Clivio, V Torri, VICTOR Study Group. Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study. Breast Cancer Res Treat. 2021 Dec;190(3):415-424. doi: 10.1007/s10549-021-06375-5.

 

  1. Elena Maccaroni, Riccardo Giampieri, Edoardo Lenci, Laura Scortichini, Francesca Bianchi, Laura Belvederesi, Cristiana Brugiati, Silvia Pagliaretta, Elisa Ambrosini, Rossana Berardi. BRCA mutations and gastrointestinal cancers: When to expect the unexpected? World J Clin Oncol 2021 July 24; 12(7): 565-580 DOI: 10.5306/wjco.v12.i7.565.

 

  1. Chengzhi Zhou, Shiyue Li, Jun Liu, Qian Chu, Liyun Miao, Linbo Cai, Xiuyu Cai, Yu Chen, Fei Cui, Yuchao Dong, Wen Dong, Wenfeng Fang, Yong He, Weifeng Li, Min Li, Wenhua Liang, Gen Lin, Jie Lin, Xinqing Lin, Hongbing Liu, Ming Liu, Xinlin Mu, Yi Hu, Jie Hu, Yang Jin, Ziming Li, Yinyin Qin, Shengxiang Ren, Gengyun Sun, Yihong Shen, Chunxia Su, Kejing Tang, Lin Wu, Mengzhao Wang, Huijuan Wang, Kai Wang, Yuehong Wang, Ping Wang, Hongmei Wang, Qi Wang, Zhijie Wang, Xiaohong Xie, Zhanhong Xie, Xin Xu, Fei Xu, Meng Yang, Boyan Yang, Xiangjun Yi, Xiaoqun Ye, Feng Ye, Zongyang Yu, Dongsheng Yue, Bicheng Zhang, Jian Zhang, Jianqing Zhang, Xiaoju Zhang, Wei Zhang, Wei Zhao, Bo Zhu, Zhengfei Zhu, Wenzhao Zhong, Chunxue Bai, Liangan Chen, Baohui Han, Chengping Hu, Shun Lu, Weimin Li, Yong Song, Jie Wang, Caicun Zhou, Jianying Zhou, Yanbin Zhou, Yuichi Saito, Yoshinobu Ichiki, Hitoshi Igai, Satoshi Watanabe, Sara Bravaccini, Alfonso Fiorelli, Francesco Petrella, Takeo Nakada, Piergiorgio Solli, Nikolaos Tsoukalas, Yuki Kataoka, Taichiro Goto, Rossana Berardi, Jianxing He, Nanshan Zhong. International consensus on severe lung cancer-the first edition. Transl Lung Cancer Res 2021 Jun; 10(6):2633-2666. doi: 10.21037/tlcr-21-467.

 

  1. D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, M Campone, I Bondarenko, Z Nowecki, H Errihani, S Paluch-Shimon, A Wardley, J-L Merot, P Trask, Y du Toit, C Pena-Murillo, V Revelant, D Klingbiel, T Bachelot, PERUSE investigators. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication. Ann Oncol 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024.

 

  1. Laura Pizzuti, Maddalena Barba, Marco Mazzotta*, Eriseld Krasniqi, Marcello Maugeri‑Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto & Patrizia Vici. The prognostic relevance of HER2‑positivity gain in metastatic breast cancer in the ChangeHER trial. Scientific Reports | (2021) 11:13770 | https://doi.org/10.1038/s41598-021-92774-z.

 

  1. Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni G. Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maio, Lorenzo Fornaro, Giovanni L. Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro and Filippo Pietrantonio*. TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite. InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. Cancers 2021, 13, 2839. https://doi.org/10.3390/cancers13112839.

 

  1. Ammad Ahmad Farooqi, Sawera Nayyab, Chiara Martinelli, Rossana Berardi, Hector Katifelis, Maria Gazouli and William C. Cho*. Regulation of Hippo, TGFb/SMAD, Wnt/b-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer. Frontiers in Oncology June 2021 | Volume 11 | Article 657965. published: 09 June 2021 doi: 10.3389/fonc.2021.657.

 

  1. Xun Yuan, Zhiqin Zheng, Fangfang Liu, Yuan Gao, Wenhui Zhang, Rossana Berardi, Pranshu Mohindra, Zhengfei Zhu, Jie Lin, Qian Chu.  A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy. Transl Lung Cancer Res 2021;10(5):2163-2171 | http://dx.doi.org/10.21037/tlcr-21-211.

 

  1. Mirco Pistelli, Valentina Natalucci, Laura Scortichini, Veronica Agostinelli, Edoardo Lenci, Sonia Crocetti, Filippo Merloni, Lucia Bastianelli, Marina Taus, Daniele Fumelli, Gloria Giulietti, Claudia Cola, Marianna Capecci, Roberta Serrani, Maria Gabriella Ceravolo, Maurizio Ricci, Albano Nicolai, Elena Barbieri, Giulia Nicolai, Zelmira Ballatore, Agnese Savini and Rossana Berardi. The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience. Cancers 2021, 13, 5539. https://doi.org/10.3390/cancers13215539.

 

  1. Valentina Natalucci, Francesco Lucertini, Luciana Vallorani, Giorgio Brandi, Manuela Marchegiani, Mirco Pistelli, Rossana Berardi, Maria Gabriella Ceravolo, Elena Barbieri, Marianna Capecci. A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study. Helyon, 7 2021. Doi: https://doi.org/10.1016/j.heliyon.2021.e08252.

 

  1. Alberto Murrone, Luca Cantini, Federica Pecci, Valeria Cognigni, Cecilia Copparoni, Silvia Rinaldi, Ilaria Fiordoliva, Federica Monaco, Corrado Rubini, Francesca Barbisan, Alessia Cimadamore, Riccardo Giampieri, Francesca Bianchi, Marco Tomasetti, Monica Amati, Lory Santarelli, Rossana Berardi. BAP1 and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma. J Thorac Dis 2021 | https://dx.doi.org/10.21037/jtd-21-555.

 

  1. Zelmira Ballatore, Filippo Merloni, Nicoletta Ranallo, Lucia Bastianelli, Francesca Vitarelli, Luca Cantini, Giulia Ricci, Benedetta Ferretti, Paolo Alessandroni, Michela Del Prete, Silvia Chiorrini, Mobin Safi, Rita Ficarelli, Giovanni Benedetti, Luca Faloppi, Massimo Marcellini, Rosa Stoico, Rossana Berardi. Cancer patient perspective during COVID-19 pandemic. Psycho-Oncology, 2021 DOI: 10.1002/pon.5774

 

  1. Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni G. Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maio, Lorenzo Fornaro, Giovanni L. Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro and Filippo Pietrantonio. TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II. INFINITY Study. Cancers 2021, 13, 2839. https://doi.org/10.3390/cancers13112839.

 

  1. Luca Cantini, Federica Pecci, Floris Dammeijer, Joachim G.J.V. Aerts, Rossana Berardi. Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced nonesmall cell lung cancer patients. European Journal of Cancer, 2021, https://doi.org/10.1016/j.ejca.2021.05.016

 

  1. Ammad Ahmad Farooqi, Rukset Attar, Ishmuratova Margarita Yulaevna, Rossana Berardi. Interaction of long non-coding RNAs and circular RNAs with microRNAs for the regulation of immunological responses in human cancers. Semin Cell Dev Biol 2021 Jun 3;S1084-9521(21)00138-5. doi: 10.1016/j.semcdb.2021.05.029

 

  1. F. Conforti, M. Marino, V. Vitolo, L. Spaggiari, R. Mantegazza, P. Zucali, E. Ruffini, L. di Tommaso, G. Pelosi, M. Barberis, I. Petrini, G. Palmieri, G. Pasello, G. Galli, R. Berardi, M. Garassino, P. Filosso, M. Alloisio, M. Scorsetti, R. Orecchia, L. Pala, L. Abatedaga, S. Cinieri & T. De Pas. Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM), ESMO Open 2021 Jun 8;6(4):100188. doi: 10.1016/j.esmoop.2021.100188.

 

  1. Federica Pecci, Luca Cantini, Alessandro Bittoni, Edoardo Lenci, Alessio Lupi, Sonia Crocetti, Enrica Giglio, Riccardo Giampieri, Rossana Berardi. Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer, 2021 Curr. Treat. Options in Oncol. (2021) 22:69 DOI 10.1007/s11864-021-00870-z

 

  1. Rossana Berardi, Roberto Papa, Valerio Mattia Scandali, Mariangela Torniai, Maurizio Blasi, Andrea Brusa, Franco Elisei, Gian Luca Gregori, Giancarlo Laurenzi, Luca Marinelli, Massimiliano Marinelli, Graziella Mazzoli, Fabrizio Volpini, Michele Caporossi. Contrasting Fake News in Oncology: The First Declaration of Good Communication. JCO Glob Oncol 2021 May;7:740-746. doi: 10.1200/GO.21.00003.

 

  1. Luca Cantini, Lucia Bastianelli, Alessio Lupi, Giada Pinterpe, Federica Pecci, Giovanni Belletti, Rosa Stoico, Francesca Vitarelli, Marco Moretti, Nicoletta Onori, Riccardo Giampieri, Marco Bruno Luigi Rocchi and Rossana Berardi. Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J. Clin. Med. 2021, 10, 1503. https://doi.org/10.3390/jcm10071503

 

  1. G. L. Banna, A. Cortellini, D. L. Cortinovis, M. Tiseo, J. G. J. V. Aerts, F. Barbieri, R. Giusti, E. Bria, F. Grossi, P. Pizzutilo, R. Berardi, A. Morabito, C. Genova, F. Mazzoni, V. Di Noia, D. Signorelli, A. Gelibter, M. Macerelli, F. Rastelli, R. Chiari, D. Rocco, S. Gori, M. De Tursi, P. Di Marino, G. Mansueto, F. Zoratto, M. Filetti, M. Montrone, F. Citarella, R. Marco, L. Cantini, O. Nigro, E. D'Argento, S. Buti, G. Minuti, L. Landi, G. Guaitoli, G. Lo Russo, A. De Toma, C. Donisi, A. Friedlaender, A. De Giglio, G. Metro, G. Porzio, C. Ficorella, A. Addeo. The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ‡ 50% advanced non-small-cell lung cancer. ESMO Open 2021 Jun;6(3):100137. Doi: 10.1016/j.esmoop.2021.100137.

 

  1. Riccardo Giampieri, Luca Cantini, Michela Del Prete, Alessandro Bittoni, Enrica Giglio, Alessandra Mandolesi, Elena Maccaroni, Andrea Lanese, Tania Meletani, Maria Giuditta Baleani, Renato Bisonni, Marina Scarpelli and Rossana Berardi. An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer. Oncology Letters 21: 267, 2021 Doi: 10.3892/Ol.2021.12528.

 

  1. Edoardo Lenci, Giulia Marcantognini, Valeria Cognigni, Alessio Lupi, Silvia Rinaldi, Luca Cantini, Ilaria Fiordoliva, Anna Lisa Carloni, Marco Rocchi, Lina Zuccatosta, Stefano Gasparini, Rossana Berardi. Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis. Explor Target Antitumor Ther. 2021;2:[Online First]. https://doi.org/10.37349/etat.2021.00043

 

  1. Alessio Cortellini, Massimo Di Maio, Olga Nigro, Alessandro Leonetti, Diego L Cortinovis, Joachim GJV Aerts, Giorgia Guaitoli, Fausto Barbieri, Raffaele Giusti, Miriam G Ferrara, Emilio Bria, Ettore D'Argento, Francesco Grossi, Erika Rijavec, Annalisa Guida, Rossana Berardi, Mariangela Torniai, Vincenzo Sforza, Carlo Genova, Francesca Mazzoni, Marina Chiara Garassino, Alessandro De Toma, Diego Signorelli, Alain Gelibter, Marco Siringo, Paolo Marchetti, Marianna Macerelli, Francesca Rastelli, Rita Chiari, Danilo Rocco, Luigi Della Gravara, Alessandro Inno, De Tursi Michele, Antonino Grassadonia, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Daniele Santini, Fabrizio Citarella, Marco Russano, Luca Cantini, Alessandro Tuzi, Paola Bordi, Gabriele Minuti, Lorenza Landi, Serena Ricciardi, Maria R Migliorino, Francesco Passiglia, Paolo Bironzo, Giulio Metro, Vincenzo Adamo, Alessandro Russo, Gian Paolo Spinelli, Giuseppe L Banna, Alex Friedlaender, Alfredo Addeo, Katia Cannita, Corrado Ficorella, Giampiero Porzio, David J Pinato. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. J Immunother Cancer 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

 

  1. Alessio Cortellini, Andrea De Giglio, Katia Cannita, Diego L. Cortinovis, Robin Cornelissen, Cinzia Baldessari, Raffaele Giusti, Ettore D’Argento, Francesco Grossi, Matteo Santoni, Annamaria Catino, Rossana Berardi, Vincenzo Sforza, Giovanni Rossi, Lorenzo Antonuzzo, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Mario Alberto Occhipinti, Alessandro Follador, Francesca Rastelli, Rita Chiari, Luigi Della Gravara, Alessandro Inno, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Maria Vittoria Pensieri, Marco Russano, Luca Cantini, Olga Nigro, Alessandro Leonetti, Paola Bordi, Gabriele Minuti, Lorenza Landi, Alessandro De Toma, Clelia Donisi, Serena Ricciardi, Maria Rita Migliorino, Valerio Maria Napoli, Gianmarco Leone, Giulio Metro, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study. Thoracic Cancer. 2021;12:880–889. DOI: 10.1111/1759-7714.13852

 

  1. B. Pellegrino, L. Cavanna, D. Boggiani, C. Zamagni, A. Frassoldati, A. Schirone, A. Caldara, A. Rocca, S. Gori, F. Piacentini, R. Berardi, A. A. Brandes, J. Foglietta, F. Villa, R. Todeschini, M. Tognetto, N. Naldi, B. Bortesi, F. Montemurro, A. Ardizzoni, L. Boni & A. Musolino. Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). Published by Elsevier Ltd on behalf of European Society for Medical Oncology, 2020. Volume 6 - Issue 1 - 2021 https://doi.org/10.1016/j.esmoop.2020.100019.

 

  1. Francesco Cognetti, Riccardo Masetti, Alessandra Fabi, Giulia Bianchi, Donatella Santini, Alessia Rognone, Giovanna Catania, Domenico Angelucci, Giuseppe Naso, Mario Giuliano, Lucia Vassalli, Patrizia Vici, Giovanni Scognamiglio, Daniele Generali, Alberto Zambelli, Marco Colleoni, Corrado Tinterri, Francesco Scanzi, Leonardo Vigna, Paola Scavina, Teresa Gamucci, Emilia Marrazzo, Angelo Fedele Scinto, Rossana Berardi, Maria Agnese Fabbri, Graziella Pinotti, Daniela Franco, Daniela Andreina Terribile, Giuseppe Tonini, Daniela Cianniello and Sandro Barni. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy. npj Breast Cancer (2021) 7:47 ; https://doi.org/10.1038/s41523-021-00246-4.
  2. Mirco Pistelli, Filippo Merloni, Sonia Crocetti, Laura Scortichini, Laura Tassone, Luca Cantini, Veronica Agostinelli, Lucia Bastianelli, Agnese Savini, and Rossana Berardi. Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience. Journal of Oncology Volume 2021, Article ID 5548252, 7 pages. https://doi.org/10.1155/2021/5548252
  3. Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, Sergio Bracarda, Massimo Di Maio, Raffaele Giusti, Olga Nigro, Diego L. Cortinovis, Joachim G.J.V. Aerts, Giorgia Guaitoli, Fausto Barbieri, Miriam G. Ferrara, Emilio Bria, Francesco Grossi, Claudia Bareggi, Rossana Berardi, Mariangela Torniai, Luca Cantini, Vincenzo Sforza, Carlo Genova, Rita Chiari, Danilo Rocco, Luigi Della Gravara, Stefania Gori, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Fabrizio Citarella, Marco Russano, Francesca Mazzoni, Marina C. Garassino, Alessandro De Toma, Diego Signorelli, Alain Gelibter, Marco Siringo, Alessandro Follador, Renato Bisonni, Alessandro Tuzi, Gabriele Minuti, Lorenza Landi, Serena Ricciardi, Maria R. Migliorino, Fabrizio Tabbo, Emanuela Olmetto, Giulio Metro, Vincenzo Adamo, Alessandro Russo, Gian P. Spinelli, Giuseppe L. Banna, Alfredo Addeo, Alex Friedlaender, Katia Cannita, Giampiero Porzio, Corrado Ficorella, Luca Carmisciano, David J. Pinato, Giulia Mazzaschi, Marcello Tiseo, Alessio Cortellini. Predictive ability of a drug-based score in patients with advanced nonesmall-cell lung cancer receiving first-line immunotherapy. European Journal of Cancer, 150 (2021) 224-231. https://doi.org/10.1016/j.ejca.2021.03.041.
  4. Stefano Cascinu, Rossana Berardi, Roberto Bianco, Domenico Bilancia, Alberto Zaniboni, Daris Ferrari, Stefania Mosconi, Andrea Spallanzani, Luigi Cavanna, Silvana Leo, Francesca Negri, Giordano D. Beretta, Alberto Sobrero, Maria Banzi, Alberto Morabito, Alessandro Bittoni, Roberta Marciano, Domenica Ferrara, Silvia Noventa, Maria C. Piccirillo, Roberto Labianca, Cristina Mosconi, Andrea Casadei Gardini, Ciro Gallo, Francesco Perrone. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer e A GISCAD phase II randomized trial. European Journal of Cancer 148 (2021) 422-429. https://doi.org/10.1016/j.ejca.2021.02.023.
  5. Alessio Cortellini, Katia Cannita, Marcello Tiseo, Diego L. Cortinovis, Joachim G.J.V. Aerts, Cinzia Baldessari, Raffaele Giusti, Miriam G. Ferrara, Ettore D’Argento, Francesco Grossi, Annalisa Guida, Rossana Berardi, Alessandro Morabito, Carlo Genova, Lorenzo Antonuzzo, Francesca Mazzoni, Alessandro De Toma, Diego Signorelli, Alain Gelibter, Giada Targato, Francesca Rastelli, Rita Chiari, Danilo Rocco, Stefania Gori, Michele De Tursi, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Sergio Bracarda , Fabrizio Citarella, Russano Marco, Luca Cantini, Olga Nigro, Sebastiano Buti, Gabriele Minuti, Lorenza Landi, Serena Ricciardi, Maria R. Migliorino, Salvatore Natalizio, Carnio Simona, Marco De Filippis, Giulio Metro, Vincenzo Adamo, Alessandro Russo, Gian P. Spinelli, Massimo Di Maio, Giuseppe L. Banna, Alex Friedlaender, Alfredo Adde. First prospective outcomes of NSCLC patients with PDL1 expression > 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. European Journal of Cancer 148 (2021) 24-35. https://doi.org/10.1016/j.ejca.2021.02.005

 

  1. Alessandro Bittoni, Federica Pecci, Giulia Mentrasti, Sonia Crocetti, Alessio Lupi, Andrea Lanese, Chiara Pellei, Chiara Ciotti, Luca Cantini, Riccardo Giampieri, Edoardo Lenci, Enrica Giglio, Federica Bini, Cecilia Copparoni, Tania Meletani, Maria Giuditta Baleani, Rossana Berardi. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer. Ann Transl Med 2021;9(3):251 | http://dx.doi.org/10.21037/atm-20-3499

 

  1. Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C. Dingemans, Joachim G. J. V. Aerts and Rossana Berardi. The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. J. Clin. Med. 2021, 10, 1005. https://doi.org/10.3390/jcm10051005.

 

  1. Alberto Bongiovanni, Flavia Foca, Manuela Fantini, Maria Rosachiara Forcignanò, FabrizioArtioli, Rossana Berardi, Enrico Campadelli, Giuseppe Procopio, Francesco Silvestris, Nada Riva, LorenaGurrieri, SilviaAngela Debonis, Giandomenico Di Menna, Valentina Fausti, Federica Recine, RobertoVespignani & Toni Ibrahim. First prospective data on breast cancer patients from the multicentre italian bone metastasis database. Scientifc Reports | (2021) 11:4329 | https://doi.org/10.1038/s41598-021-83749-1

 

  1. Sonia Crocetti, Laura Tassone, Mariangela Torniai, Chiara Pierantoni, Luciano Burattini, Alessandra Mandolesi, Maika Di Benedetto, Giovanna Mantello, Marina Scarpelli, Rossana Berardi. Seminoma Retroperitoneal Relapse 23 Years After Surgery. Oncol Ther https://doi.org/10.1007/s40487-021-00141-9

 

  1. Luca Cantini, Federica Pecci, Filippo Merloni, Andrea Lanese, Edoardo Lenci, Francesco Paoloni, Joachim G.J.V. Aerts, Rossana Berardi. Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC. Explor Target Antitumor Ther. 2021;2:[Online First]. https://doi.org/10.37349/etat.2021.00030

 

  1. Berardi R, Torniai M, Cona MS, Cecere F, Chiari R, Guarneri V, La Verde N, Locati L, Lorusso D, Martinelli E, Giannarelli D. & Garassino M. On behalf of Women for Oncology Italy. Social distress and gender imbalance among Health Care Professionals during the first wave of COVID-19 pandemic in Italy, ESMO open, 2021; https://doi.org/10.1016/j.esmoop.2021.100053

 

 

 

 

 

 

 

b. Books chapters:

 

  1. Rossana Berardi. Il cuore delle donne in Oncologia. Capitolo 11. Pag. 93-97. Le Donne incontrano la Salute, esperienze e riflessioni. Laura Patrucco, Gregorio Cosentino. 2022.

 

  1. Rossana Berardi, Alessandro Bittoni, Riccardo Giampieri. Neoplasie dello Stomaco. Sez. II. Cap. 16. Manuale di Oncologia Medica II Edizione. COMU Collegio degli Oncologi Medici Italiani a cura di Massimo Aglietta, 2022, Edizioni Minerva Medica.ISBN 978-88-5532-094-8.

 

  1. Rossana Berardi e Silvia Rinaldi. Prognostic and predictive role of bone metastasis in NSCLC: risk factor and clinical implications. Chapter, 4. Unrevealing the complexities of Metastasis, 2022. https://doi.org/10.1016/B978-0-12-821789-4.00018-7.

 

  1. Ammad Farooqi, Muhammad Qureshi, Uteuliyev Sabitaliyevi. Unraveling the Complexities of Metastasis Transition from a Segmented View to a Conceptual Continuum 1st Edition - May 1, 2022 - Paperback ISBN: 9780128217894

 

  1. Rossana Berardi, Francesca Morgese, Silvia Rinaldi, Mariangela Torniai, Daniele Santini. Emergenze nel paziente oncologico. Manuale di Oncologia Medica II Ed. - Edizioni Minerva Medica 2021.
  2. Rossana Berardi, Alessandro Bittoni, Riccardo Giampieri. Neoplasie dello stomaco. Cap.16 . Manuale di Oncologia Medica II Ed. - Edizioni Minerva Medica 2021.

c. Abstract selection:

 

  1. Francesca Rossi, Alessandro Parisi, Alessia Bianchi, Elena Boni, Paolo Pompilii, Enio Prendi, Valentina Tarantino, Riccardo Giampieri, Rossana Berardi. Gender oncology: differences in epidemiology, clinical outcome and toxicity in the two sexes. A narrative review, 2023.

 

  1. Antonio Avallone, Giuseppe Aprile, Michele Aieta, Cristina Granetto, Andrea Bonetti, Giovanni Luca Frassineti, Rossana Berardi, Silvia Vecchiarelli, Francesco Giuliani, Patrizia Racca, Davide Tassinari, Chiara Manai, Giancarlo Paoletti, Dario Bruzzese, Daniela Terracciano, Evelina La Civita, Carlo Buonerba. FLIBER - Serum cytokine levels as predictors of the efficacy of aflibercept in combination with FOLFIRI in metastatic Colo-Rectal Cancer patients (mCRC). Abstract accepted as e-poster presentation at AIOM (Associazione Italiana di Oncologia Medica) Congress, 1-3 Ottobre 2022.
  2. G. Mentrasti, E. Ambrosini, L. Giuliani, N. Chiodi, C. Liguori, M. Gualtieri, F. Bianchi, F. Barbisan, G. Goteri, M.B.L. Rocchi, R. Berardi. 1621P-miRNA signature as early predictor of hyponatremia and survival in lung cancer: preliminary results from the ISA retrospective study. Abstract accepted as e-poster presentation at ESMO (European Society of Medical Oncolology) Congress, 9-13 Settembre 2022.
  3. Santiago Ponce, Oscar Juan‑Vidal, Enric Carcereny, José Trigo, Mariano Provencio, Laurent Greillier, Alejandro Navarro, Jaafar Bennouna, Armando Santoro, Rossana Berardi, Benjamin Besse, Héctor González, Juan de Alvaro, Josep L. Parra‑Palau, Tania Sánchez‑Pérez, Ida Aronchik, Ellen Filvaroff, Manisha Lamba, Zariana Nikolova, Luis‑Paz Ares. Phase 1b study of CC‑90011, a potent, reversible, oral LSD1 inhibitor, plus etoposide and cisplatin or carboplatin in patients with first‑line extensive‑stage small cell lung cancer: updated results. Abstract accepted as e-poster presentation at European Lung Cancer Congress Virtual, 25-27 March 2021.
  4. Cantini L. A Phase 1b Study of CC-90011, a Potent, Reversible, Oral LSD1 Inhibitor, Plus Etoposide and Cisplatin (EP) or Carboplatin (EC) in Patients (Pts) With First-Line (1L) Extensive-Stage (ES) Small Cell Lung Cancer (SCLC): Updated Results. Accepted for e-Poster presentation at ELCC 2021 Virtual, to be held 25-27 March 2021.